OrbiMed Asia Partners II LP
- Fund Information and Directors
| OrbiMed Asia Partners II LP |
| Firm |
OrbiMed Advisors LLC
|
| Fund # | 805-4969310917 |
| CIK # | 0001584561 |
| Sale |
|
| Fund | Other Private Fund |
| Phone | 2127396400 |
| Address | c/o OrbiMed Advisors LLC
New York, New York 10022 |
| Source |
[EDGAR]
[IAPD]
|
| Fund AUM and Sold ($M) |
|
|
| Fund Details |
| Director | OrbiMed Asia GP II LP |
| Custodian | Citibank NA, Merrill Lynch Pierce Fenner & Smith Incorporated, Shanghai Pudong Development Bank, Citibank India NA, Silicon Valley Bank, JPMorgan Chase Bank NA, Afrasia Bank Limited, Citigroup Global Markets Inc, China International Capital Corporation |
| Auditor | Rothstein Kass & Company PC, KPMG LLP |
| Marketer | Merrill Lynch Pierce Fenner & Smith Incorporated, Merrill Lynch International & Co CV |
| Broker | |
| Jurisdiction | |
| Form D Offering |
| Filed | 2013-08-15 (D) |
| Exemption | 506, 3(c), 3(c)(7) |
| Remaining | $300,000,000 |
| Duration | One year or less |
| Revenue | Not Applicable |
| Investors | 415 |
{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "stripe_subscribe": "/stripe-subscribe", "update_card": "/update-card"}
{"uid": 217137392, "pid": -1, "pid_a": [], "name": "", "email": "", "blacklist_f": false, "paywall_f": false, "paywall_n": 0, "random_n": 0}
False
325367403